HFSA Board Certification Review 2021

HFSA Board Certification Review 2021

Heart Failure Fundamentals (Pre-Recorded)

Heart Failure Epidemiology and Risk Factors

Sadiya Khan

Pathophysiology I: Cellular and Energetic Considerations

Daniel Burkhoff

Pathophysiology II: Hemodynamic, Structural, and Neurohormonal Considerations

Daniel Burkhoff

Diagnosis and Clinical Assessment

Mark Drazner

Cardio-Oncology for the HF boards

Bonnie Ky

Clinico-Pathologic Correlates in Heart Failure/ Images for the Heart Failure Boards

Jon Lomasney

Statistics for the HF Board

Brian Claggett

Cardiac Transplantation

Advanced Heart Failure: Defining the Phenotype and Patient Selection for Advanced Therapies

Nancy Sweitzer

Immunology: The Basics, PRA, Sensitization, Crossmatch

Sean Pinney

Rejection: Cellular and Antibody Mediated

Sean Pinney

Managing Immunosuppression and Drugs

Michelle Kittleson

Heart Transplant, Clinical Outcomes and Complications

Michelle Kittleson

Q&A Panel I

Akshay Desai, Nancy Sweitzer, Jonathan Rich, Maria Rosa

Key Issues in HF Management

Hemodynamics in HF I

James Fang

Hemodynamics in HF II

James Fang

Drug Therapy for Chronic HF I: Focus on established therapies (ACE/ARB/Beta-blocker/MRA/Digoxin/Hydralazine+Nitrates)

Clyde Yancy

Drug Therapy for Chronic HF II: Focus on newer therapies (Sacubitril/Valsartan, Ivabradine, SGLT2 inhibitors)

Mark Drazner

HFpEF: Epidemiology, Risk Factors, Diagnosis, Management (for the boards)

Sanjiv Shah

Pulmonary Hypertension

Jonathan Rich

Management of Common Arrhythmias I – Atrial Fib and Flutter

Roderick Tung

Management of Common Arrhythmias in HF II

Roderick Tung

Device Therapy in Heart Failure I – Sudden Death Prevention

Wendy Tzou

Device Therapy in Heart Failure II – CRT

Wendy Tzou

Management of the Hospitalized HF Patient

Maria Rosa Costanzo

Cardio Renal Failure Interactions in Heart Failure

Jeff Testani

Specific Heart Failure Syndromes

Specific Etiologies of HF I: Common Etiologies (CAD, ETOH, Peripartum, Myocarditis)

Akshay Desai

Specific Etiologies of HF II: Inherited HF syndromes (including HCM, ARVC, and LVNC)

Jane Wilcox

Specific Etiologies of HF III: Infiltrative Disorders and Restrictive Cardiomyopathy (Amyloidosis, Sarcoidosis, Hemochromatosis, Fabry)

Sanjiv Shah

Q&A Panel II

Akshay Desai, Nancy Sweitzer, Jonathan Rich, Maria Rosa

Guest: James Fang

Shock/MCS

Cardiogenic Shock Management

Nancy Sweitzer

MCS I: Durable MCS Devices and Outcomes

Joseph Rogers

MCS II: Temporary Support Devices and ECMO for the Boards

Jennifer Cowger

MCS III: MCS Complications and Patient Management

Jennifer Cowger

MCS IV: Interactive Shock and Device Management

Daniel Burkhoff, Jennifer Cowger, Joseph Rogers, Nancy Sweitzer

Special Topics in HF

Assessment of Functional Capacity including cardiopulmonary exercise testing

Gregory Lewis

Adult Congenital Heart Disease for the HF Specialist

Eric Krieger

Issues in Chronic HF Disease Management (Biomarkers, Remote Monitoring, Lifestyle Interventions)

Akshay Desai

Management of Valvular Heart Disease in Heart Failure (including functional MR, low gradient AS, tricuspid regurgitation)

Jane Wilcox

Management of Comorbidities in Heart Failure – Diabetes, Sleep Disorders, Iron Deficiency/Anemia, COPD

Maria Rosa Costanzo

Q&A Panel III

Akshay Desai, Nancy Sweitzer, Jonathan Rich